APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microarray Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Microarray Services Market Outlook and Growth Opportunities 2026

29 December 2025208 pages

Choose your research edition.

Industry ResearchMicroarray Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Microarray Services Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Microarray Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microarray Services Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Microarray Services Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Microarray Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microarray Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microarray Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microarray Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microarray Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microarray Services market include Merck, Thermo Fisher Scientific, SCHOTT, Psomagen, PerkinElmer, OGT, Molecular Devices, LC Sciences and Illumina, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Microarray Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microarray Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microarray Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microarray Services market.

Microarray Services Segment by Company

Merck

Thermo Fisher Scientific

SCHOTT

Psomagen

PerkinElmer

OGT

Molecular Devices

LC Sciences

Illumina

Hokkaido System Science

GE Healthcare

Creative Biolabs

CD Genomics

Bio-Rad Laboratories

Bionexus

Arrayit

Agilent

Affymetrix

Microarray Services Segment by Type

Gene Expression Microarray

Genotyping Microarray

Methylation Microarray

Transcriptome Microarray

Microarray Services Segment by Application

Drug Development

Medical Research

Others

Microarray Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Microarray Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Microarray Services key companies, revenue, market share, and recent developments.

3. To split the Microarray Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Microarray Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microarray Services significant trends, drivers, influence factors in global and regions.

6. To analyze Microarray Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microarray Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microarray Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microarray Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microarray Services industry.

Chapter 3: Detailed analysis of Microarray Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Microarray Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Microarray Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microarray Services Industry Trends Table 2. Microarray Services Industry Drivers Table 3. Microarray Services Industry Opportunities and Challenges Table 4. Microarray Services Industry Restraints Table 5. Global Microarray Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microarray Services Revenue Share by Company (2021-2026) Table 7. Global Microarray Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Microarray Services Key Company Manufacturing Base & Headquarters Table 9. Global Microarray Services Company, Product Type & Application Table 10. Global Microarray Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Microarray Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gene Expression Microarray Table 15. Significant Companies of Genotyping Microarray Table 16. Significant Companies of Methylation Microarray Table 17. Significant Companies of Transcriptome Microarray Table 18. Global Microarray Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Microarray Services Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Microarray Services Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Microarray Services Sales Value Share by Type (2021-2026) Table 22. Global Microarray Services Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Drug Development Table 24. Significant Companies of Medical Research Table 25. Significant Companies of Others Table 26. Global Microarray Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Microarray Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Microarray Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Microarray Services Sales Value Share by Application (2021-2026) Table 30. Global Microarray Services Sales Value Share by Application (2027-2032) Table 31. Global Microarray Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Microarray Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Microarray Services Sales Value Share by Region (2021-2026) Table 34. Global Microarray Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Microarray Services Sales Value Share by Region (2027-2032) Table 36. Global Microarray Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Microarray Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Microarray Services Sales Value Market Share by Country (2021-2026) Table 39. Global Microarray Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Microarray Services Sales Value Market Share by Country (2027-2032) Table 41. Merck Company Information Table 42. Merck Business Overview Table 43. Merck Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Merck Microarray Services Product Portfolio Table 45. Merck Recent Development Table 46. Thermo Fisher Scientific Company Information Table 47. Thermo Fisher Scientific Business Overview Table 48. Thermo Fisher Scientific Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Thermo Fisher Scientific Microarray Services Product Portfolio Table 50. Thermo Fisher Scientific Recent Development Table 51. SCHOTT Company Information Table 52. SCHOTT Business Overview Table 53. SCHOTT Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. SCHOTT Microarray Services Product Portfolio Table 55. SCHOTT Recent Development Table 56. Psomagen Company Information Table 57. Psomagen Business Overview Table 58. Psomagen Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Psomagen Microarray Services Product Portfolio Table 60. Psomagen Recent Development Table 61. PerkinElmer Company Information Table 62. PerkinElmer Business Overview Table 63. PerkinElmer Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. PerkinElmer Microarray Services Product Portfolio Table 65. PerkinElmer Recent Development Table 66. OGT Company Information Table 67. OGT Business Overview Table 68. OGT Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. OGT Microarray Services Product Portfolio Table 70. OGT Recent Development Table 71. Molecular Devices Company Information Table 72. Molecular Devices Business Overview Table 73. Molecular Devices Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Molecular Devices Microarray Services Product Portfolio Table 75. Molecular Devices Recent Development Table 76. LC Sciences Company Information Table 77. LC Sciences Business Overview Table 78. LC Sciences Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. LC Sciences Microarray Services Product Portfolio Table 80. LC Sciences Recent Development Table 81. Illumina Company Information Table 82. Illumina Business Overview Table 83. Illumina Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Illumina Microarray Services Product Portfolio Table 85. Illumina Recent Development Table 86. Hokkaido System Science Company Information Table 87. Hokkaido System Science Business Overview Table 88. Hokkaido System Science Microarray Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Hokkaido System Science Microarray Services Product Portfolio Table 90. Hokkaido System Science Recent Development Table 91. GE Healthcare Company Information Table 92. GE Healthcare Business Overview Table 93. GE Healthcare Microarray Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GE Healthcare Microarray Services Product Portfolio Table 95. GE Healthcare Recent Development Table 96. Creative Biolabs Company Information Table 97. Creative Biolabs Business Overview Table 98. Creative Biolabs Microarray Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Creative Biolabs Microarray Services Product Portfolio Table 100. Creative Biolabs Recent Development Table 101. CD Genomics Company Information Table 102. CD Genomics Business Overview Table 103. CD Genomics Microarray Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. CD Genomics Microarray Services Product Portfolio Table 105. CD Genomics Recent Development Table 106. Bio-Rad Laboratories Company Information Table 107. Bio-Rad Laboratories Business Overview Table 108. Bio-Rad Laboratories Microarray Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Bio-Rad Laboratories Microarray Services Product Portfolio Table 110. Bio-Rad Laboratories Recent Development Table 111. Bionexus Company Information Table 112. Bionexus Business Overview Table 113. Bionexus Microarray Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Bionexus Microarray Services Product Portfolio Table 115. Bionexus Recent Development Table 116. Arrayit Company Information Table 117. Arrayit Business Overview Table 118. Arrayit Microarray Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Arrayit Microarray Services Product Portfolio Table 120. Arrayit Recent Development Table 121. Agilent Company Information Table 122. Agilent Business Overview Table 123. Agilent Microarray Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Agilent Microarray Services Product Portfolio Table 125. Agilent Recent Development Table 126. Affymetrix Company Information Table 127. Affymetrix Business Overview Table 128. Affymetrix Microarray Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Affymetrix Microarray Services Product Portfolio Table 130. Affymetrix Recent Development Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Microarray Services Product Image Figure 2. Global Microarray Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microarray Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Microarray Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gene Expression Microarray Image Figure 8. Genotyping Microarray Image Figure 9. Methylation Microarray Image Figure 10. Transcriptome Microarray Image Figure 11. Global Microarray Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Microarray Services Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Microarray Services Sales Value Share by Type (2021-2032) Figure 14. Drug Development Image Figure 15. Medical Research Image Figure 16. Others Image Figure 17. Global Microarray Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Microarray Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Microarray Services Sales Value Share by Application (2021-2032) Figure 20. Global Microarray Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Microarray Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Microarray Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Microarray Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Microarray Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Microarray Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Microarray Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Microarray Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Microarray Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Microarray Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Microarray Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Microarray Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Microarray Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Microarray Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Microarray Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Expression Microarray
  • Genotyping Microarray
  • Methylation Microarray
  • Transcriptome Microarray
Applications
  • Drug Development
  • Medical Research
  • Others
Companies covered
  • Merck
  • Thermo Fisher Scientific
  • SCHOTT
  • Psomagen
  • PerkinElmer
  • OGT
  • Molecular Devices
  • LC Sciences
  • Illumina
  • Hokkaido System Science
  • GE Healthcare
  • Creative Biolabs
  • CD Genomics
  • Bio-Rad Laboratories
  • Bionexus
  • Arrayit
  • Agilent
  • Affymetrix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microarray Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microarray Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Microarray Services Market Dynamics
  1. 2.1 Microarray Services Industry Trends
  2. 2.2 Microarray Services Industry Drivers
  3. 2.3 Microarray Services Industry Opportunities and Challenges
  4. 2.4 Microarray Services Industry Restraints
3 Microarray Services Market by Company
  1. 3.1 Global Microarray Services Company Revenue Ranking in 2025
  2. 3.2 Global Microarray Services Revenue by Company (2021-2026)
  3. 3.3 Global Microarray Services Company Ranking (2024-2026)
  4. 3.4 Global Microarray Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Microarray Services Company Product Type and Application
  6. 3.6 Global Microarray Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Microarray Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Microarray Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Microarray Services Market by Type
  1. 4.1 Microarray Services Type Introduction
  2. 4.1.1 Gene Expression Microarray
  3. 4.1.2 Genotyping Microarray
  4. 4.1.3 Methylation Microarray
  5. 4.1.4 Transcriptome Microarray
  6. 4.2 Global Microarray Services Sales Value by Type
  7. 4.2.1 Global Microarray Services Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Microarray Services Sales Value by Type (2021-2032)
  9. 4.2.3 Global Microarray Services Sales Value Share by Type (2021-2032)
5 Microarray Services Market by Application
  1. 5.1 Microarray Services Application Introduction
  2. 5.1.1 Drug Development
  3. 5.1.2 Medical Research
  4. 5.1.3 Others
  5. 5.2 Global Microarray Services Sales Value by Application
  6. 5.2.1 Global Microarray Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Microarray Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Microarray Services Sales Value Share by Application (2021-2032)
6 Microarray Services Regional Value Analysis
  1. 6.1 Global Microarray Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microarray Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Microarray Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Microarray Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microarray Services Sales Value (2021-2032)
  7. 6.3.2 North America Microarray Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Microarray Services Sales Value (2021-2032)
  10. 6.4.2 Europe Microarray Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Microarray Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Microarray Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Microarray Services Sales Value (2021-2032)
  16. 6.6.2 South America Microarray Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Microarray Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Microarray Services Sales Value Share by Country, 2025 VS 2032
7 Microarray Services Country-level Value Analysis
  1. 7.1 Global Microarray Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microarray Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Microarray Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Microarray Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Microarray Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Microarray Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Microarray Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Microarray Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Microarray Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Microarray Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Microarray Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Microarray Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Microarray Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Microarray Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Microarray Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Microarray Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Microarray Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Microarray Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Microarray Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Microarray Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Microarray Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Microarray Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Microarray Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Microarray Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Microarray Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Microarray Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Microarray Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Microarray Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Microarray Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Microarray Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Microarray Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Microarray Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Microarray Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Microarray Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Microarray Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Microarray Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Microarray Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Microarray Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Microarray Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Microarray Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Microarray Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Microarray Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Microarray Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Microarray Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Microarray Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Microarray Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Microarray Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Microarray Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Microarray Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Microarray Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Microarray Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Microarray Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Microarray Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Microarray Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Microarray Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Microarray Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Microarray Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Microarray Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Microarray Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Microarray Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Microarray Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Microarray Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Microarray Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Microarray Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Microarray Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Microarray Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Microarray Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Microarray Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Microarray Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Microarray Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Microarray Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Microarray Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Microarray Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Microarray Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Microarray Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Microarray Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Microarray Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Microarray Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Microarray Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Microarray Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Microarray Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Microarray Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Microarray Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Microarray Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Microarray Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Microarray Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Microarray Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Microarray Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Microarray Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Microarray Services Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Microarray Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Microarray Services Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 SCHOTT
  14. 8.3.1 SCHOTT Company Information
  15. 8.3.2 SCHOTT Business Overview
  16. 8.3.3 SCHOTT Microarray Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SCHOTT Microarray Services Product Portfolio
  18. 8.3.5 SCHOTT Recent Developments
  19. 8.4 Psomagen
  20. 8.4.1 Psomagen Company Information
  21. 8.4.2 Psomagen Business Overview
  22. 8.4.3 Psomagen Microarray Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Psomagen Microarray Services Product Portfolio
  24. 8.4.5 Psomagen Recent Developments
  25. 8.5 PerkinElmer
  26. 8.5.1 PerkinElmer Company Information
  27. 8.5.2 PerkinElmer Business Overview
  28. 8.5.3 PerkinElmer Microarray Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PerkinElmer Microarray Services Product Portfolio
  30. 8.5.5 PerkinElmer Recent Developments
  31. 8.6 OGT
  32. 8.6.1 OGT Company Information
  33. 8.6.2 OGT Business Overview
  34. 8.6.3 OGT Microarray Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 OGT Microarray Services Product Portfolio
  36. 8.6.5 OGT Recent Developments
  37. 8.7 Molecular Devices
  38. 8.7.1 Molecular Devices Company Information
  39. 8.7.2 Molecular Devices Business Overview
  40. 8.7.3 Molecular Devices Microarray Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Molecular Devices Microarray Services Product Portfolio
  42. 8.7.5 Molecular Devices Recent Developments
  43. 8.8 LC Sciences
  44. 8.8.1 LC Sciences Company Information
  45. 8.8.2 LC Sciences Business Overview
  46. 8.8.3 LC Sciences Microarray Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LC Sciences Microarray Services Product Portfolio
  48. 8.8.5 LC Sciences Recent Developments
  49. 8.9 Illumina
  50. 8.9.1 Illumina Company Information
  51. 8.9.2 Illumina Business Overview
  52. 8.9.3 Illumina Microarray Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Illumina Microarray Services Product Portfolio
  54. 8.9.5 Illumina Recent Developments
  55. 8.10 Hokkaido System Science
  56. 8.10.1 Hokkaido System Science Company Information
  57. 8.10.2 Hokkaido System Science Business Overview
  58. 8.10.3 Hokkaido System Science Microarray Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hokkaido System Science Microarray Services Product Portfolio
  60. 8.10.5 Hokkaido System Science Recent Developments
  61. 8.11 GE Healthcare
  62. 8.11.1 GE Healthcare Company Information
  63. 8.11.2 GE Healthcare Business Overview
  64. 8.11.3 GE Healthcare Microarray Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GE Healthcare Microarray Services Product Portfolio
  66. 8.11.5 GE Healthcare Recent Developments
  67. 8.12 Creative Biolabs
  68. 8.12.1 Creative Biolabs Company Information
  69. 8.12.2 Creative Biolabs Business Overview
  70. 8.12.3 Creative Biolabs Microarray Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Creative Biolabs Microarray Services Product Portfolio
  72. 8.12.5 Creative Biolabs Recent Developments
  73. 8.13 CD Genomics
  74. 8.13.1 CD Genomics Company Information
  75. 8.13.2 CD Genomics Business Overview
  76. 8.13.3 CD Genomics Microarray Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CD Genomics Microarray Services Product Portfolio
  78. 8.13.5 CD Genomics Recent Developments
  79. 8.14 Bio-Rad Laboratories
  80. 8.14.1 Bio-Rad Laboratories Company Information
  81. 8.14.2 Bio-Rad Laboratories Business Overview
  82. 8.14.3 Bio-Rad Laboratories Microarray Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Rad Laboratories Microarray Services Product Portfolio
  84. 8.14.5 Bio-Rad Laboratories Recent Developments
  85. 8.15 Bionexus
  86. 8.15.1 Bionexus Company Information
  87. 8.15.2 Bionexus Business Overview
  88. 8.15.3 Bionexus Microarray Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bionexus Microarray Services Product Portfolio
  90. 8.15.5 Bionexus Recent Developments
  91. 8.16 Arrayit
  92. 8.16.1 Arrayit Company Information
  93. 8.16.2 Arrayit Business Overview
  94. 8.16.3 Arrayit Microarray Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Arrayit Microarray Services Product Portfolio
  96. 8.16.5 Arrayit Recent Developments
  97. 8.17 Agilent
  98. 8.17.1 Agilent Company Information
  99. 8.17.2 Agilent Business Overview
  100. 8.17.3 Agilent Microarray Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Agilent Microarray Services Product Portfolio
  102. 8.17.5 Agilent Recent Developments
  103. 8.18 Affymetrix
  104. 8.18.1 Affymetrix Company Information
  105. 8.18.2 Affymetrix Business Overview
  106. 8.18.3 Affymetrix Microarray Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Affymetrix Microarray Services Product Portfolio
  108. 8.18.5 Affymetrix Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst